TNF Pharmaceuticals Total Liabilities 2012-2024 | TNFA

TNF Pharmaceuticals total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

TNF Pharmaceuticals Total Liabilities 2012-2024 | TNFA

TNF Pharmaceuticals total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$82.4B
Takeda Pharmaceutical (TAK)$44.4B
Astellas Pharma (ALPMY)$21.1B
Sandoz Group AG (SDZNY)$19.8B
United Therapeutics (UTHR)$16.7B
Summit Therapeutics (SMMT)$14B
Shionogi (SGIOY)$12.7B
Neurocrine Biosciences (NBIX)$12.4B
Catalent (CTLT)$10.7B
Madrigal Pharmaceuticals (MDGL)$6.9B
Orion OYJ (ORINY)$6.8B
Jazz Pharmaceuticals (JAZZ)$6.8B
Ionis Pharmaceuticals (IONS)$5.7B
Corcept Therapeutics (CORT)$5B
Crinetics Pharmaceuticals (CRNX)$4.5B
PTC Therapeutics (PTCT)$3.1B
Dyne Therapeutics (DYN)$2.9B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.6B
Arrowhead Pharmaceuticals (ARWR)$2.4B
Soleno Therapeutics (SLNO)$2.2B
Recursion Pharmaceuticals (RXRX)$1.8B
Centessa Pharmaceuticals (CNTA)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.7B
Ocular Therapeutix (OCUL)$1.6B
Harrow (HROW)$1.6B
NewAmsterdam Pharma (NAMS)$1.6B
Xencor (XNCR)$1.5B
ARS Pharmaceuticals (SPRY)$1.5B
Avadel Pharmaceuticals (AVDL)$1.4B